Could a diabetes drug curb cannabis cravings? new trial aims to find out.
NCT ID NCT07468552
First seen Mar 12, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests whether tirzepatide, a drug used for diabetes, can help people with moderate to severe cannabis use disorder cut back or stop using cannabis. One hundred adults aged 18 to 70 will receive either the drug or a placebo, and researchers will track how many days per week they stay cannabis-free and how well they tolerate the medication. The goal is to see if this approach is safe and effective for managing cannabis dependence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.